Manufacturing
Medsintez Plant is a modern biotechnological enterprise where drugs go through all stages of their life cycle: from the development to sales.
On the plant's premises, a research lab complex has been created to carry out scientific and practical work on the development and study of new domestic medicines, as well as an experimental area for testing and scaling the developed technologies. |
Technological equipment from the world's leading manufacturers, which allows to produce high-quality products and successfully pass certification, was mounted at the plant. |
Our experts have extensive experience in promoting innovative medicines. Currently, Medsintez products are sold in all territorial entities of the Russian Federation and abroad. Fruitful cooperation with state bodies on programs for supplying the population with affordable drugs is going on. |
Full-Cycle Production
Production capacity of infusion solutions - 24 million containers per year. It allows to satisfy 20% of Russian demand for infusion solutions.
Production capacity of recombinant human albumin enables to satisfy up to 100 % Russia’s necessities of these products.
Production capacity of recombinant and analogue human insulins: up to 200 kg of the API per year enables to satisfy up to 100 % Russia’s necessities of insulin drugs.
Production capacity of recombinant human follicle-stimulating hormone: 150 grams of API per year (CHO cells), which is eight times higher Russia's domestic market demand.
Production capacity of recombinant human albumin enables to satisfy up to 100 % Russia’s necessities of these product.
Production capacity allows satisfying 100% of Russia's demand for recombinant and analogue human insulins, veterinary insulins, glucagon-like peptide-1 analogues and 200% for recombinant human follicle-stimulating hormone.
Production of disposable pre-filled and reusable injection pens, autoinjectors.
Production capacity of PVC bags for infusion solutions and blood processing solutions: up to 30 million pieces per year.
Production capacity of high-density polyethylene bags: up to 40 million pieces per year.
Production capacity of solutions for automatic apheresis allows 100% to satisfy the current demand in Russia for these solutions.
Quality
Quality, safety and efficacy of medicines are «Medsitntez» plant's top priorities.
The Quality Director's service structure, which includes the quality control and assurance departments, is in full compliance with GMP standards.
The core staff was trained at Bayer AG in Leverkusen and Berlin. All plant employees were trained in GMP requirements at special training organizations or at the enterprise itself.
The plant has the МС ISO 9001:2015 quality control system in place.
Quality control of finished products is carried out in the plant's laboratories accredited by Roszdravnadzor and FMBA of the Russian Federation.
The Medsintez Plant’s awards:
A prize of the Russian Government
for achieving significant results in terms of quality and services, as well as for the implementation of highly effective management techniques (2007)
A prize of the Commonwealth of Independent States
for achievements in the field of product and service quality (2009)
The plant successfully passes numerous Russian and foreign inspections annually.
Torgovaya 15, Novouralsk, Sverdlovsk region, Russia, 624130